Authors: Hidalgo, M Aylesworth, C Hammond, LA Britten, CD Weiss, G Stephenson, J Schwartz, G Patnaik, A Smith, L Molpus, K Felton, S Gupta, E Ferrante, KJ Tortora, A Sonnichsen, DS Skillings, J Rowinsky, EK

Citation: M. Hidalgo et al., Phase I and pharmacokinetic study of BMS-184476, a taxane with greater potency and solubility than paclitaxel, J CL ONCOL, 19(9), 2001, pp. 2493-2503

Authors: Meropol, NJ Sonnichsen, DS Birkhofer, MJ Ferreira, I Noel, D

Citation: Nj. Meropol et al., Bioavailability and phase II study of oral UFT plus leucovorin in patientswith relapsed or refractory colorectal cancer (vol 43, pg 221, 1999), CANC CHEMOT, 47(3), 2001, pp. 282-282

Authors: Woo, MH Relling, MV Sonnichsen, DS Rivera, GK Pratt, CB Pui, CH Evans, WE Alberto, AS

Citation: Mh. Woo et al., Phase I targeted systemic exposure study of paclitaxel in children with refractory acute leukemias, CLIN CANC R, 5(3), 1999, pp. 543-549

Authors: Meropol, NJ Sonnichsen, DS Birkhofer, MJ Ferreira, I Noel, D

Citation: Nj. Meropol et al., Bioavailability and phase II study of oral UFT plus leucovorin in patientswith relapsed or refractory colorectal cancer, CANC CHEMOT, 43(3), 1998, pp. 221-226